Fagron Overview
- Year Founded
-
1990
- Status
-
Public
- Employees
-
4,880
- Stock Symbol
-
FAGR
- Investments
-
50
- Share Price
-
$26.74
- (As of Friday Closing)
Fagron General Information
Description
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
Contact Information
Website
www.fagron.comCorporate Office
- Fascinatio Boulevard 350
- 3065 WB Rotterdam
- Netherlands
Corporate Office
- Fascinatio Boulevard 350
- 3065 WB Rotterdam
- Netherlands
Fagron Stock Performance
As of 13-Nov-2026, Fagron’s stock price is $26.74. Its current market cap is $1.96B with 73.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $26.74 | $26.85 | $23.28 - $29.44 | $1.96B | 73.4M | 98K | $1.47 |
Fagron Financials Summary
As of 30-Jun-2026, Fagron has a trailing 12-month revenue of $1.2B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,347,301 | 2,206,487 | 1,559,231 | 1,641,024 |
| Revenue | 1,199,788 | 1,074,052 | 943,547 | 825,614 |
| EBITDA | 220,010 | 200,000 | 166,299 | 139,370 |
| Net Income | 107,013 | 102,671 | 87,167 | 76,337 |
| Total Assets | 1,741,639 | 1,460,204 | 1,127,478 | 1,113,087 |
| Total Debt | 726,849 | 549,991 | 401,346 | 405,398 |
Fagron Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fagron Comparisons
Industry
Financing
Details
Fagron Competitors (10)
One of Fagron’s 10 competitors is Farmalabor, a Corporation company based in Canosa Di Puglia, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Farmalabor | Corporation | Canosa Di Puglia, Italy | ||||
| Fagron Nederland | Corporation | Capelle aan den IJssel, Netherlands | ||||
| Medisca (Pharmaceuticals) | Corporation | Saint-Laurent, Canada | ||||
| Fagron (Spain) | Corporation | Terrassa, Spain | ||||
| Fagron South Africa | Corporation | Johannesburg, South Africa |
Fagron Patents
Fagron Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3479857-A1 | Seal for locking a syringe | Inactive | 03-Nov-2017 | ||
| EP-3703793-A1 | Seal for locking a syringe | Inactive | 03-Nov-2017 | ||
| WO-2019086590-A1 | Seal for locking a syringe | Inactive | 03-Nov-2017 | ||
| EP-3266458-A1 | Method and composition and kit for treating erectile dysfunction | Inactive | 05-Jul-2016 | A61K31/5575 |
Fagron Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Fagron Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Fagron Acquisitions (50)
Fagron’s most recent deal was a Merger/Acquisition with Vepakum Embalagens for . The deal was made on 01-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vepakum Embalagens | 01-Mar-2026 | Merger/Acquisition | Plastic Containers and Packaging | ||
| Pharmavit Europe | 26-Feb-2026 | Merger/Acquisition | Distributors/Wholesale | ||
| MagiLab | 01-Feb-2026 | Merger/Acquisition | Pharmaceuticals | ||
| Amara (Pharmaceuticals) | 01-Jan-2026 | Merger/Acquisition | Pharmaceuticals | ||
| SB Trade | 01-Jan-2026 | Merger/Acquisition | BPO/Outsource Services |
Fagron ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
Fagron Exits (5)
Fagron’s most recent exit was on 30-Sep-2009 from Duomed. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Duomed | 30-Sep-2009 | Completed |
|
||
| Logiciel Julie | 03-Apr-2008 | Completed |
|
||
| Owandy | 01-Apr-2008 | Completed |
|
||
| Polichimica | 26-Jun-2007 | Completed |
|
||
| Eurotec Dental | 01-Jan-2006 | Merger/Acquisition | Completed |
Fagron Affiliates
Subsidiaries (27)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SB Trade | London, United Kingdom | 2020 | |
| Curaphar | Nuenen, Netherlands | 2015 | |
| CareFirst Specialty Pharmacy | Mount Laurel, NJ | 2014 | |
| Active Pharma Supplies | Leyland, United Kingdom | 2012 | |
| Specialist Pharmacy | Dagenham, United Kingdom | 2009 |
Fagron FAQs
-
When was Fagron founded?
Fagron was founded in 1990.
-
Where is Fagron headquartered?
Fagron is headquartered in Rotterdam, Netherlands.
-
What is the size of Fagron?
Fagron has 4,880 total employees.
-
What industry is Fagron in?
Fagron’s primary industry is Pharmaceuticals.
-
Is Fagron a private or public company?
Fagron is a Public company.
-
What is Fagron’s stock symbol?
The ticker symbol for Fagron is FAGR.
-
What is the current stock price of Fagron?
As of 13-Nov-2026 the stock price of Fagron is $26.74.
-
What is the current market cap of Fagron?
The current market capitalization of Fagron is $1.96B.
-
What is Fagron’s current revenue?
The trailing twelve month revenue for Fagron is $1.2B.
-
Who are Fagron’s competitors?
Farmalabor, Fagron Nederland, Medisca (Pharmaceuticals), Fagron (Spain), and Fagron South Africa are some of the 10 competitors of Fagron.
-
What is Fagron’s annual earnings per share (EPS)?
Fagron’s EPS for 12 months was $1.47.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
